VEGFB ameliorates insulin resistance in NAFLD via the PI3K/AKT signal pathway
Abstract Background Non-alcoholic fatty liver disease (NAFLD) is one of the most universal liver diseases with complicated pathogenesis throughout the world. Insulin resistance is a leading risk factor that contributes to the development of NAFLD. Vascular endothelial growth factor B (VEGFB) was des...
| Published in: | Journal of Translational Medicine |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-10-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12967-024-05621-w |
